As of January 22, 2025, Nanoform Finland Oyj (NANOFH.HE) has a market cap of $0.11 billion USD. According to our data, Nanoform Finland Oyj is ranked No.7602 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.11 B |
-9.51%
|
Dec 29, 2024 | $0.12 B |
-12.15%
|
Dec 28, 2023 | $0.14 B |
-50.62%
|
Dec 29, 2022 | $0.29 B |
-51.37%
|
Dec 29, 2021 | $0.59 B |
-7.06%
|
Dec 29, 2020 | $0.63 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Nanobiotix
NBTX
|
$0.16 B |
-0.000 M
|
France
|
BioNTech
BNTX
|
$27.52 B |
-0.001 M
|
Germany
|
Moderna
MRNA
|
$15.09 B |
1.280 B
|
USA
|
Pfizer
PFE
|
$148.34 B |
-0.006 M
|
USA
|
Novartis
NVS
|
$197.43 B |
0.007 M
|
Switzerland
|
AstraZeneca
AZN
|
$211.43 B |
0.005 M
|
UK
|
Sanofi
SNY
|
$128.55 B |
0.003 M
|
France
|
Merck
MRK
|
$242.59 B |
0.007 M
|
USA
|
Johnson & Johnson
JNJ
|
$347.78 B |
-0.005 M
|
USA
|
Gilead Sciences
GILD
|
$116.07 B |
0.004 M
|
USA
|
Amgen
AMGN
|
$147.53 B |
0.002 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.86 B |
0.003 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$75.23 B |
1.245 B
|
USA
|
Market Cap | = | NANOFH.HE Stock Price | * | NANOFH.HE Shares Outstanding |
= | $1.31 | * | 85.53 M | |
= | $0.11 B |